AKT1 and pachyonychia congenita: We next investigated the contribution of the AKT–GSK-3β–β-catenin pathway to the chemoresistance-promoting effect of TRIM37 in PC cells by performing rescue experiments with LY294002 and XAV-939, which are small molecule inhibitors of PI3K and β-catenin, respectively.